XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Revenue $ 204 $ 332 $ 1,050 $ 745
Cost of revenue (71) (230) (488) (366)
Gross profit 133 102 562 379
Selling, General and Administrative expenses (2,228) (1,574) (5,272) (4,943)
Research and development expenses (903) (806) (2,918) (2,968)
Operating loss (2,998) (2,278) (7,628) (7,532)
Impairment Loss on PPE (2,623) 0 (2,623) 0
Other income, net 32 29 136 56
Loss before income taxes (5,589) (2,249) (10,115) (7,476)
Income tax expense/benefit 0 0 0 0
Net loss attributable to common stockholders (5,589) (2,249) (10,115) (7,476)
Foreign currency translation adjustments 18 (61) (36) (462)
Comprehensive loss $ (5,571) $ (2,310) $ (10,151) $ (7,938)
Net loss per share attributable to common stockholders:        
Basic and diluted (in Dollars per share) $ (0.09) $ (0.04) $ (0.18) $ (0.14)
Weighted-average number of shares used in computing net loss per share amounts: (in Shares) 63,725,084 53,063,473 57,039,035 52,412,830